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Effect of lemongrass water extract supplementation 
on atherogenic index and antioxidant status in rats
Cymbopogon citratus (DC) Stapf., commonly known as le-
mon grass, possesses strong antioxidant and cardiotonic 
pro per ties. Lemongrass water extract contains several 
polypheno lic compounds including gallic acid, isoquerce-
tin, quer cetin, rutin, catechin and tannic acid. Rutin, iso-
quercetin catechin and quercetin are the flavonoids most 
abundantly found in the extract. The extract significantly 
decreased total cholesterol, low-density lipoprotein and 
atherogenic index in rats after treatment (p < 0.05). Ex-
pression of genes and protein of sterol regulatory element 
binding protein-1c (SREBP1c) and HMG-CoA reductase 
(HMGR) was also lowered significantly in treated groups 
(p < 0.05). Moreover, serum antioxidant capacity increased 
in treated rats in comparison with untreated ones (p < 0.05) 
and was associat ed with decreased serum lipid peroxida-
tion. 
Keywords: Cymbopogon citratus, lipid profile, antioxidant, 
SREBP1c, HMG-CoA reductase
High consumption of vegetables containing phytochemicals with antioxidant proper-
ties seems to be a protective factor against atherosclerosis (1). Treatment with statins, in-
hibitors of HMG-CoA reductase (HMGR), results in inhibition of endogenous cholesterol 
synthesis and is associated with regression of coronary atherosclerosis when LDL is sub-
stantially reduced and HDL is increased (2). However, plasma lipoprotein regulation is a 
complex process. Besides HMGR expression, the sterol regulatory element binding pro-
tein-1c (SREBP1c) is one of the major transcriptional regulators that induce key lipogenic 
enzymes to promote lipogenesis in the liver. Inhibition of SREBP1 could potentially im-
prove hypertriglyceridemia and hepatic steatosis outcomes (3).
Cymbopogon citratus (DC) Stapf. (Poaceae), lemongrass, is a widely used herb in tro pi-
cal countries. Lemongrass is used as a flavoring agent in food. In addition, lemongrass tea 
is a refreshing beverage. Phytochemicals such as flavonoids, alkaloids, volatile and non-
volatile terpenoids, carotenoids and tannins have been identified from lemongrass (4). A 
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of cardiovascular diseases and that even relatively small amounts of flavonoid-rich nour-
ishments might be beneficial (5). Although some studies address the health benefits and 
metabolic effects of lemongrass extract, there are few studies of the prolonged consump-
tion of the extract in healthy subjects. Therefore, this study was aimed at investigating the 
effects of the consumption of lemongrass aqueous extract (CCW) on the atherogenic index 
(AI) and antioxidant status in rats. Water extract was investigated because lemongrass 
decoction is the most commonly used form.
EXPERIMENTAL
Plant material
The plant was cultivated in Khon Kaen Province, Thailand, and was collected in No-
vember 2014. Its botanical identity was determined and authenticated by a taxonomist. A 
voucher specimen is deposited in the herbarium of the Faculty of Pharmaceutical Sciences, 
Prince of Songkla University, Songkla Province, Thailand.
Extraction
Collected plant material (whole plants) was washed thoroughly with clean water, cut 
into small pieces, boiled in distilled water (1 g of plant material in 10 mL of water) for 1 h and 
then filtered. Filtrates were concentrated using a rotary vacuum evaporator and subsequently 
lyophilized. Water extract yield was 4.0 %. The extract was stored at –80 °C until use.
Analyses of phytochemicals in CCW extract
Total phenolic content was analyzed using the Folin-Ciocalteu method (6). Gallic acid 
was used as a reference standard and the results were expressed as gallic acid equivalents 
(GAE).
Total flavonoids were determined using aluminum chloride according to a previously 
published method (7), using catechin as a standard. The results were expressed as catechin 
equivalents (CE).
Phenolic compounds in the CCW extract were further quantitated by high-perfor-
mance liquid chromatography with diode array detection and a mass spectrometry detec-
tor (HPLC-DAD/MSD) (8). Briefly, phenolic compounds were separated using an Agilent 
1100 series HPLC system (Agilent Technologies, Germany), equipped with a LiChroCART 
Stainless Steel Purospher STAR RP-18E column (150 mm × 4.6 mm, particle size 5 μm) 
(Merck, Germany) and a diode array detector recording at 270, 330, 350 and 370 nm. The 
binary mobile phase consisted of acetonitrile (solvent A) and 10 mmol L–1 ammonium 
formate buffer, pH 4, with formic acid (solvent B). Separation of compounds was carried 
out with a gradient (0–5 min B 100 %, 5–10 min A 0–20 %, 10–20 min A 20 %, 20–60 min A 
20–40 %). The flow rate was 1 mL min–1.
In addition to identification of compounds by comparison with the reference standard 
retention time (tR), mass spectrometry detection was carried out using an Agilent Mass 
Selective Detector system (Agilent Technologies, USA) to confirm and identify the compo-
nents in unresolved chromatographic peaks. Briefly, nitrogen was used as the nebulizing 
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gas with a flow rate of 13 L min–1 at 320 °C. Capillary voltages were set at 4000 V (positive) 
and 3000 V (negative). A scan time of 0.2 s with m/z range of 100–700 was employed.
All standard compounds were purchased from Sigma-Aldrich (USA). Data acquisi-
tion was performed with Chemstation software A.08.03 (Agilent Technologies, USA). CCW 
extract was analyzed against phenolic standards. Standard calibration curves were estab-
lished by plotting the areas of peaks against different concentrations. Limit of detection 
(LOD) was estimated based on signal-to-noise ratio of 3 being considered as acceptable.
1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay
Radical scavenger efficiency of CCW extract was evaluated using the DPPH radical 
scavenging activity assay following the method previously described (9).
Experimental animals and design
Thirty healthy adult male Sprague-Dawley rats were supplied by the National Animal 
Center, Mahidol University, Thailand. Animals were allowed ad libitum access to stan-
dard rat chow and water. They were divided into five groups of six rats each. The group I 
(control group) animals were orally administered vehicle solution (distilled water) for 30 
days. The animals in groups II-IV were orally administered CCW extract, which was dis-
solved in distilled water, at doses of 250, 500 and 1,000 mg kg–1 bm per day, resp., for 30 
days. The animals in group V were orally administered simvastatin dissolved in distilled 
water at a daily dose of 10 mg kg–1 bm.
The animal procedure of this study was approved by the Animal Research Committee 
of Thammasat University, Thailand. All institutional and national rules for the care and 
utilization of laboratory animals were followed.
Antioxidant status and lipid peroxidation in rats
The total antioxidant capacity (TAC) in serum was assessed with Abcam’s Total Anti-
oxidant Capacity Assay Kit (ab65329, Abcam, UK) as per the manufacturer’s instructions. 
Serum catalase (CAT) and superoxide dismutase (SOD) activities were assessed using a 
catalase assay kit and a superoxide dismutase assay kit (Cayman Chemical Company, 
USA), resp., according to the manufacturer’s instructions. Malondialdehyde (MDA), the 
marker of lipid peroxidation, was measured in serum as a thiobarbituric acid reactive 
substance (TBAR) following a previously reported method (10).
Body/organ masses and biochemical parameters
Masses of animals and internal organs, including the heart, kidneys, liver and pan-
creas, were measured at the end of the experiment. Blood was taken from rat ś heart by 
cardiac puncture. Serum was centrifuged at 2,000 g at 4 °C for 10 min. Biochemical markers 
of liver and kidney function, including aspartate aminotransferase (AST) and alanine ami-
notransferase (ALT), blood urea nitrogen (BUN) and serum creatinine (Cr), as well as lipid 
profiles, including triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL) 
and low density lipoprotein (LDL), were measured in the laboratory unit of the Thamma-
sat University Hospital, Pathumthani Thailand.
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Total RNA was extracted from the liver tissue using the TRIzol® reagent, following the 
manufacturer’s instructions (Thermo Fisher Scientific, USA ). The ImProm-II™ Reverse 
Transcription System (Promega Corporation, USA) was used for total RNA reverse tran-
scription. PCR amplification was performed using specific primers for the SERBP1c, HMGR 
and the internal control, which was glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
Primer sequences were as follows: i) HMGR forward primer 5′-CATGCTGCCAACATCGT-
CA-3′ and reverse primer 5′-CCCACATTCTGTGCTGCATC-3′(11), ii) SERBP1c forward primer 
5′-CCTGGTGGTGGGCACTGA-3′ and reverse primer 5′-GTGCTGTAAGAAGCGGATG-
TAGTC-3′, and iii) GADPH forward primer 5′-TGTTCTAGAGACAGCCGCATCTT-3′ and 
reverse primer 5′-CCGACCTTCACCATCTTGTCTAT-3′ (12). Gene expression was measured 
using real-time fluorescence PCR. It was carried out with ABI StepOnePlus (Applied Biosys-
tems, USA) using SsoFast™ EvaGreen® Supermix with low ROX (Bio-Rad, USA). Negative 
controls (template with deionized water) were included in each run. Amplification data were 
collected and analyzed with StepOne software V2.2.2 (Applied Biosystems).
Western blot analysis
Western blot analysis was used to determine the protein expression of SERBP1c or 
HMGR and β-actin. Fresh liver was washed with ice-cold phosphate-buffered saline (PBS), 
homogenized with cell lysis buffer (Cell Signaling Technology, USA) with the addition of 
protease inhibitor cocktail M221 (Amresco, USA) at 4 °C. After vigorous vortex mixing and 
centrifuging, the supernatant was collected and the protein content was determined. Sample 
protein was mixed with sodium dodecyl sulfate (SDS) loading buffer and subjected to 
electrophoretic separation. The bands were blotted onto a polyvinylidene fluoride (PVDF) 
membrane. After being blocked with 5 % (m/V) skimmed milk powder in PBS containing 
0.1 % Tween20 at room temperature for 1 h, the PVDF membranes were incubated over-
night with primary antibodies [mouse monoclonal anti-SERBP1c (sc-365513), rabbit poly-
clonal anti-HMGR (sc-33827), and mouse polyclonal anti-β-actin (sc-8432) antibodies] in 
PBS at 4 °C. After being washed with PBS, the blots were incubated for 1 h at room tem-
perature with horseradish peroxidase (HRP)-labeled secondary antibodies (anti-rabbit 
IgG-HRP, sc-2004, anti-mouse IgG-HRP, sc-2005, Santa Cruz Biotechnology, USA). After 
incubation, the blots were washed with PBS and processed for chemiluminescence detec-
tion using an enhanced chemiluminescence (ECL) reagent (Amersham™ ECL™ prime 
western blotting detection reagent, GE Healthcare, USA). Densities of each specific protein 
bands were visualized and analyzed with the aid of Image Studio version 2.1 software 
(Odyssey Fc Imaging System, LI-COR® Biosciences, USA).
Histopathological examination
After treatment with CCW extract (at doses of 250, 500 and 1,000 mg kg–1 bm per day) 
or simvastatin (at a dose of 10 mg kg–1 bm per day) for 30 days, the animals were sacrificed 
by isoflurane euthanasia. The tissues (rat liver and aorta) were immediately fixed in 4 % 
paraformaldehyde and embedded in paraffin. A series of 5-μm thick sections was stained 
with hematoxylin-eosin (H&E). The H&E stained slides were examined under a photomi-
croscope.
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All data were expressed as mean ± SEM. Significant differences (p < 0.05) between 
experimental groups were analyzed using the analysis of variance (ANOVA) with Duncan 
post-hoc test. ANOVA on the rank test was used for non-parametric analysis.
RESULTS AND DISCUSSION
Phytochemical analysis and antioxidant property of CCW extract
According to phytochemical screening, the CCW extract contained flavonoids, 496 ± 
85 mg kg–1 CE, and phenolic compounds, 402 ± 13 mg kg–1 GAE. The DPPH assay showed 
that 920 ± 23 mg mL–1 extract induced 50 % free radical scavenging inhibition.
At least six polyphenolic compounds were identified in CCW extract, including gallic 
acid (tR = 6.93 min), isoquercetin (tR = 16.50 min), quercetin (tR = 33.94 min), rutin (tR = 15.36 
min), catechin (tR = 12.57 min) and tannic acid (tR = 12.89 min) (Fig. 1). Along with retention 
Fig. 1. HPLC-DAD chromatograms of: a) standard mixture: A – gallic acid, B – catechin, C – tannic 
acid, D – rutin, E – isoquercetin, F – hydroquinone, G – eriodictyol, H – quercetin; b) representative 
sample of CCW. The diode array detector was set at 270 nm.
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time, the resulting product ion from mass spectrometry detection was used as a finger-
print of each compound (Table I). These results suggest that CCW extract is a phenolics-
rich extract with rutin, isoquercetin, catechin and quercetin as most abundant.
General toxicity of CCW extract
For clinical signs of toxicity of CCW extract after multiple doses, the general appear-
ance and behavior of animals were observed. In this study, there were no differences in 
general appearance and behavior of animals between the groups after multiple doses of 
CCW compared with the normal control. No statistically significant differences were 
found between body mass changes and the mass of vital organs (liver, kidney and heart) 
among the groups (Table II). Histopathological examination was performed to show no 
abnormality in the liver of any of the animals (Fig. 2a). Serum AST, ALT, BUN and Cr levels 






(mg kg–1 dry extract)
Gallic acid 6.93 188, 209 474.66
Catechin 12.57 185, 329, 503, 649 898.64
Tannic acid 12.89 185, 329, 503, 649 432.43
Rutin 15.36 185, 329, 503, 649 1032
Isoquercetin 16.5 185, 329, 503, 649 989.03
Hydroquinone 22.97 289, 327, 341 NDa 
Eriodictyol 31.33 289, 327, 341 NDa
Quercetin 33.94 289, 327, 341 738.81
ND – not detected, a Limit of detection: 10 mg kg–1.
Table II. Relative organ masses of rats after 30 days of CCW treatment
Group Body mass bm (g)
Heart
(g per 100 g bm)
Kidney
(g per 100 g bm)
Pancreas
(g per 100 g bm)
Liver
(g per 100 g bm)
Control 373 ± 17 0.38 ± 0.01 0.70 ± 0.03 0.30 ± 0.02 3.40 ± 0.33
CCW 250 364 ± 6 0.39 ± 0.01 0.73 ± 0.03 0.34 ± 0.03 3.29 ± 0.15
CCW 500 374 ± 11 0.42 ± 0.06 0.78 ± 0.03 0.37 ± 0.04 3.33 ± 0.23
CCW 1000 349 ± 19 0.34 ± 0.06 0.73 ± 0.02 0.38 ± 0.03 3.28 ± 0.28
Simvastatin 347 ± 12 0.40 ± 0.06 0.72 ± 0.03 0.36 ± 0.02 3.26 ± 0.18
Dosing regime over 30 days: CCW 250, CCW 500, CCW 1000 rats fed CCW extract: 250, 500 or 1000 mg kg–1 bm 
daily, resp.; simvastatin rats: 10 mg kg–1 bm daily, control group: vehicle solution.
Mean  ± SEM (n = 6).
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remained unchanged (Table III). Thus, liver and kidney functions were not affected by the 
CCW administration. These results indicated that CCW water extract administration was 
safe at daily doses up to 1,000 mg kg-1 for at least 30 days.
Fig. 2. Histological section of: a) liver and b) rats’ aorta after treatment. Representative slides of cor-
responding groups. Adv – tunica adventitia, Int – tunica intima, Med – tunica media, PV – branch of 
portal vein, s – sinusoid.
Table III. Biochemical parameters in rat serum after 30 days of CCW treatment
 Group AST ALT BUN Cr
 (U L–1) (U L–1) (mg per 100 mL) (mg per 100 mL)
Control    20.33 ± 0.61 0.38 ± 0.07 194.54 ± 15.08 65.50 ± 3.42
CCW 250    19.33 ± 0.80 0.43 ± 0.62 193.83 ± 8.98 77.67 ± 8.45
CCW 500    21.50 ± 1.98 0.38 ± 0.09 196.83 ± 24.01 64.17 ± 2.75
CCW 1000    18.00 ± 1.59 0.39 ± 0.04 191.50 ± 13.00 58.83 ± 2.87
Simvastatin    19.80 ± 1.79 0.39 ± 0.07 194.50 ± 11.00 61.63 ± 4.57
AST – aspartate aminotransferase, ALT – alanine aminotransferase, BUN – blood urea nitrogen, Cr – creatinine 
Dosing regime over 30 days: CCW 250, CCW 500, CCW 1000 rats fed CCW extract: 250, 500 or 1000 mg kg–1 bm 
daily, resp.; simvastatin rats: 10 mg kg–1 bm daily, control group: vehicle solution. 
Mean ± SEM (n = 6).
a)                                                                                   b)
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Effects of CS extract on lipid peroxidation and antioxidant status
In this study, the basal lipid peroxidation in serum was decreased in rats treated with 
CCW extract in a dose-dependent manner (Table IV). The antioxidant activities of SOD and 
CAT were significantly induced by CCW treatment at all doses (Table IV). Serum TAC was 
found to be slightly increased compared to the control group (Table IV) (p < 0.05). An in-
crease in the SOD, CAT and diminished lipid peroxidation levels was observed in rutin 
and quercetin pretreated rats (13). Furthermore, a significant decrease in the level of MDA, 
along with increased CAT and SOD activities, in catechin-treated rats was (14). Since rutin, 
isoquercetin, catechin and quercetin were the major phenolic compounds present in CCW, 
the modulation of SOD, CAT and lipid peroxidation in the CCW-treated group could 
potentially be due to the effect of these compounds.







(mmol L–1, Trolox 
equivalents)
Control     76.66 ± 0.95 0.036 ± 0.01 3.36 ± 0.01 1.50 ± 0.09
CCW 250    64.45 ± 1.29* 0.038 ± 0.01 4.25 ± 0.11* 1.66 ± 0.07
CCW 500    56.66 ± 0.71* 0.041 ± 0.03*   4.22 ± 0.05* 1.70 ± 0.16
CCW 1000   50.01 ± 0.69* 0.066 ± 0.01* 4.84 ± 0.03* 1.82 ± 0.04*
Simvastatin 57.51 ± 1.69* 0.039 ± 0.01* 4.24 ± 0.03* 1.62 ± 0.08
CAT – catalase, MDA – malondialdehyde, SOD – superoxide dismutase, TAC – total antioxidant capacity
Dosing regime over 30 days: CCW 250, CCW 500, CCW 1000 rats fed CCW extract: 250, 500 or 1000 mg kg–1 bm 
daily, resp.; simvastatin rats: 10 mg kg–1 bm daily, control group: vehicle solution. 
Mean ± SEM (n = 6).
Statistically significant difference compared with control: *p < 0.05.
Table V. Effect of CCW extract on lipid status and atherogenic index
Group TG HDL LDL TC Atherogenic index
(mg per 100 mL) (mg per 100 mL) (mg per 100 mL) (mg per 100 mL) log (TG/HDL)
Control 79.44 ± 8.66 23.63 ± 1.01 29.37 ±  8.96 94.64 ± 7.11 0.60 ± 0.06
CCW 250 67.50 ± 13.66 25.49 ± 2.13 28.61 ± 1.64 86.02 ± 7.22 0.32 ± 0.14*
CCW 500 65.88 ± 7.47 26.15 ± 3.60 23.28 ± 4.67* 78.13 ± 4.13* 0.20 ± 0.10*
CCW 1000 67.30 ± 12.81 26.54 ± 2.65 22.78 ± 2.94* 79.61 ± 6.82* 0.13 ± 0.10*,**
Simvastatin 61.14 ± 5.16* 26.76 ± 2.41 19.76 ± 2.23*,** 75.33 ± 5.13* 0.12 ± 0.12*,**
HDL – high density lipoprotein, LDL – low density lipoprotein, TC – total cholesterol, TG – triglyceride
Dosing regime over 30 days: CCW 250, CCW 500, CCW 1000 rats fed CCW extract: 250, 500 or 1000 mg kg–1 bm 
daily, resp.; simvastatin rats: 10 mg kg–1 bm daily, control group: vehicle solution. Mean ± SEM (n = 6).
Statistically significant difference: *p < 0.05 (vs. control group); ** p < 0.05 (vs. CCW 250 treated group).
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Effects of CS extract on serum lipid profiles
In addition to the antioxidant property, the serum TC and LDL concentrations in 
CCW-treated groups were found to decrease compared to those in the untreated group 
(p < 0.05), whereas the serum HDL level had a tendency to increase and TG level had a 
tendency to decrease (p = 0.09 and p = 0.08, resp.) but still not significantly, whereas treatment 
Fig. 3. a) Expression of hepatic SREBP1c and HMGR mRNA, and b) Western blot analysis of: SREBP1c 
(1 and 3) and HMGR (2 and 4) expression in rats; representative images. Each bar represents the mean 
± SEM, n = 6. Statistically significant difference vs. control: * p < 0.05.
a)
b)        1                                                                                     2
           3                                                                                     4
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with simvastatin dramatically decreased LDL concentration compared to the control and 
CCW-treated groups (p < 0.05). In particular, the administration of CCW and simvastatin 
significantly reduced the atherogenic index, the predictor of cardiovascular risk (15) com-
pared to the control group (p < 0.05, Table V). In addition, a histological study of the tho-
racic aorta was performed to assess the adaptive intima thickenings of the artery wall 
where atherosclerotic lesions are prone to develop. No changes were observed (Fig. 2b).
The present study demonstrated that the CCW extract had the ability to reduce serum 
TC and LDL levels. Some previous reports provided evidence of the flavonoid hypolipid-
emic effect and antioxidant properties, which are associated with their ability to decrease 
the plasma total cholesterol concentration and enhance the antioxidant system (16, 17). 
Influence of quercetin on the lipid profile and its anti-atherosclerotic effects have been 
reported recently (18). Catechin has been shown to up-regulate the LDL receptor and in-
crease the clearance rate of cholesterol (19). Rutin was shown to decrease the levels of lipids 
in plasma and tissues in streptozotocin-induced diabetic rats (20). Moreover, rutin alone 
or in combination with lovastatin was reported to reduce the levels of total cholesterol and 
LDL in animals on a high-cholesterol diet (21). Isoquercetin was shown to decrease total 
cholesterol and triglycerides in diabetic mice and high-cholesterol diet-treated rabbits (22).
Effects of CS extract consumption on lipid regulatory genes and proteins
To investigate whether CCW reduced serum cholesterol due to inhibition of the ex-
pression of lipid regulatory genes and proteins, RNA and protein expression analyses of 
transcription factor and enzymes involved in lipid synthesis (SERBP1c and HMGR, resp.) 
were performed. Consistent with the decreased levels of serum TC and LDL, gene expres-
sions of SREBP1c and HMGR were significantly reduced in all CCW-treated groups com-
pared to the control group (p < 0.05), as shown in Fig. 3a.
Moreover, protein expressions of SREBP1c and HMGR were also decreased after CCW 
treatment, as shown in Fig. 3b. Interestingly, HMGR protein and gene expressions were 
significantly increased in the simvastatin-treated group compared to the control (p < 0.05), 
as shown in Figs. 3a,b. However, treatment with simvastatin caused no significant change 
of SREBP1c gene and protein expression. In our study, the effects of CCW and simvastatin 
on SREBP1c and HMGR were different. Simvastatin, a competitive inhibitor of HMGR, 
caused induction of HMGR gene expression, but CCW did not exert this effect. Thus, we 
speculate that CCW may not act as a competitive inhibitor of the enzyme HMGR like sim-
vastatin (23). Its efficacy may depend on individual characteristics of active compounds.
The findings that CCW extract decreased gene and protein expression of SREBP1c and 
HMGR were in agreement with previous reports. For example, quercetin-induced LDL 
gene expression accompanied with an increase in nuclear SREBPs and decreased HMGR 
activity has been reported (24). In addition, rutin was shown to inhibit oleic acid-induced 
lipid accumulation via inhibition of HMGR transcription in HepG2 cells (25). Administra-
tion of 1 % green tea, an excellent source of catechin, to rat for 6 months showed a reduc-
tion in the gene expression of SREBP1c (26). Moreover, luteolin found in lemongrass has 
been reported (27). This compound exhibited a lipid-lowering potential by significant 
down-regulation of SREBP1c and fatty acid synthase gene expression in animal models 
(28). Thus, the effects of CCW extract on gene and protein expression of SREBP1c and 
HMGR might be mediated, at least in part, by rutin, quercetin and catechin, which we 
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found in the extract, or, even more, by more active compounds such as luteolin found in 
the plant by other authors (27, 28).
Drugs of the statin group inhibit endogenous cholesterol production by competitive 
inhibition of the enzyme HMGR (23). When rats were fed diets containing statins, an 
adverse increase of HMGR mRNA and protein was observed. However, feeding rats with a 
diet containing 0.04 % atorvastatin showed induction of HMGR mRNA and protein expres-
sion but the apparent HMGR activity was not increased to the extent of the protein levels 
(29). Moreover, in a rodent model of the metabolic syndrome (MetS rats), statin treatment 
also increased the expression of genes regulated by SREBP1c, leading to up-regulation of 
intestinal lipid secretion (30). In agreement with additional studies, we found that rats 
treated with simvastatin enhanced HMGR gene and protein expression. However, unlike 
the MetS rats, the healthy rats treated with simvastatin did not exert a significant change in 
SREBP1c gene and protein expression. This finding suggests that alternative mechanisms 
may be involved in the lipid-lowering effect of statins in distinct animal models.
CONCLUSIONS
Our study utilized a water extract of CCW that comprised rutin, isoquercetin, catechin 
and quercetin as major polyphenolic compounds. In addition to the antioxidant property, 
CCW exerted an ability to reduce the atherogenic index, serum TC and LDL levels. Its 
lipid-lowering effects were mediated, at least in part, by influencing the gene and protein 
expression of SREBP1c and HMGR. Therefore, the results support the assumption that 
CCW consumption reduces the atherogenic index and enhances the serum antioxidant 
capacity, thereby indicating its potential in reducing the risks of cardiovascular diseases. 
Further efforts are required to isolate active compounds from the extract as well as to eluci-
date their mechanisms of action.
Acronyms, abbreviations, symbols. – AI – atherogenic index, AST – aspartate aminotransferase, 
ALT – alanine aminotransferase, BUN – blood urea nitrogen, CAT – catalase, CCW – lemongrass 
aqueous extract, CE – catechin equivalents, Cr – creatinine, DPPH – 1,1-diphenyl-2-picrylhydrazyl, 
HDL – high density lipoprotein, HMGR – HMG-CoA reductase, HPLC-DAD/MSD – high-performance 
liquid chromatography with diode array and mass spectrometry detection, GAE – gallic acid equivalents, 
LDL – low density lipoprotein, MDA – malondialdehyde, SOD – superoxide dismutase, SREBP1c – 
sterol regulatory element binding protein-1c, TAC – total antioxidant capacity, TC – total cholesterol, 
TG – triglyceride.
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